Publications by authors named "Mats Jerkeman"

100Publications

National e-library for standardized chemotherapy regimens.

Acta Oncol 2020 Sep 13;59(9):1079-1083. Epub 2020 May 13.

Ergonomics and Aerosol Technology, Department of Design Sciences, Faculty of Engineering LTH, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2020.1764097DOI Listing
September 2020

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma.

Am J Hematol 2020 07 3;95(7):740-748. Epub 2020 Apr 3.

Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25789DOI Listing
July 2020

Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women.

Anticancer Res 2020 Mar;40(3):1513-1517

Department of Obstetrics & Gynecology, Skåne University Hospital, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.14096DOI Listing
March 2020

Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study.

Br J Haematol 2020 Jun 17;189(6):1083-1092. Epub 2020 Feb 17.

Clinical Epidemiology Division, Department of Medicin Solna, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16489DOI Listing
June 2020

Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases.

Pharmaceut Med 2019 04;33(2):83-88

Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 160, 2100, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40290-019-00270-7DOI Listing
April 2019

Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.

Br J Haematol 2020 04 13;189(1):106-116. Epub 2019 Nov 13.

Department of Medicine, Division of Clinical Epidemiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16317DOI Listing
April 2020

Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study.

JCO Clin Cancer Inform 2018 12;2:1-13

Jorne L. Biccler, Lasse Hjort Jakobsen, Martin Bøgsted, and Tarec C. El-Galaly, Aalborg University Hospital and Aalborg University, Aalborg; Peter de Nully Brown, Copenhagen University Hospital, Copenhagen; Henrik Frederiksen, Odense University Hospital, Odense; Judit Jørgensen, Aarhus University Hospital, Aarhus; Denmark; Sandra Eloranta and Karin E. Smedby, Karolinska Institutet, Stockholm; Mats Jerkeman, Lund University, Lund; and Karin E. Smedby, Karolinska University Hospital, Solna, Sweden.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.18.00025
Publisher Site
http://dx.doi.org/10.1200/CCI.18.00025DOI Listing
December 2018

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up.

PLoS One 2018 23;13(8):e0202651. Epub 2018 Aug 23.

Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202651PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107196PMC
February 2019

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.

Am J Hematol 2018 May 17. Epub 2018 May 17.

Division of Clinical Epidemiology, Department of Medicin Solna, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25147DOI Listing
May 2018

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

J Clin Oncol 2017 Dec 26;35(36):4019-4026. Epub 2017 Oct 26.

Matthew J. Maurer, N. Nora Bennani, Stephen M. Ansell, James R. Cerhan, and Andrew L. Feldman, Mayo Clinic, Rochester, MN; Fredrik Ellin, Kalmar County Hospital, Kalmar; Fredrik Ellin and Thomas Relander, Lund University; Mats Jerkeman and Thomas Relander, Skåne University Hospital, Lund; Karin E. Smedby, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Line Srour, Joseph M. Connors, Graham W. Slack, and Kerry J. Savage, Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; and Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.8195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736237PMC
December 2017

The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.

Br J Haematol 2017 09 8;178(5):739-746. Epub 2017 May 8.

Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.14740
Publisher Site
http://dx.doi.org/10.1111/bjh.14740DOI Listing
September 2017

Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study.

Hematol Oncol 2018 Feb 5;36(1):159-165. Epub 2017 May 5.

Department of Clinical Sciences Lund, Section for oncology and pathology, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2428DOI Listing
February 2018

Frequency and clinical implications of SOX11 expression in Burkitt lymphoma.

Leuk Lymphoma 2017 07 21;58(7):1760-1763. Epub 2016 Nov 21.

b Department of Immunotechnology , CREATE Health, Lund University , Lund , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1258701DOI Listing
July 2017

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

J Clin Oncol 2015 Dec 5;33(34):3993-8. Epub 2015 Oct 5.

Tarec Christoffer El-Galaly, Hans Erik Johnsen, and Martin Bøgsted, Aalborg University Hospital; Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Hans Erik Johnsen, and Martin Bøgsted, Aalborg University, Aalborg; Martin Hutchings and Peter de Nully Brown, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Karen Juul Mylam, Odense University Hospital, Odense, Denmark; Herman Nilsson-Ehle, Sahlgrenska University Hospital, Gothenburg; Elisabeth Székely and Mats Jerkeman, Lund University Hospital, Lund; and Viktoria Hjalmar, Karolinska Institutet, Stockholm University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.0229DOI Listing
December 2015

Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.

Hematol Oncol 2017 Jun 15;35(2):151-157. Epub 2015 Sep 15.

Lund University, Department of Clinical Sciences Lund, Department of Oncology, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2256DOI Listing
June 2017

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.

Am J Hematol 2015 Dec 6;90(12):1128-34. Epub 2015 Oct 6.

Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24184DOI Listing
December 2015

Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studies.

Eur J Haematol 2016 May 25;96(5):541-3. Epub 2015 Aug 25.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12646DOI Listing
May 2016

Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.

Blood 2015 Jul 8;126(1):36-41. Epub 2015 May 8.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-12-616961DOI Listing
July 2015

Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study.

Acta Oncol 2015 Jun 6;54(6):924-32. Epub 2015 Apr 6.

Department of Radiology, Oncology, and Radiation Sciences, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1026455DOI Listing
June 2015

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.

Acta Oncol 2015 Nov 2;54(10):1770-80. Epub 2015 Apr 2.

e Department of Medicine , Karolinska Institutet, Clinical Epidemiology Unit , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1020967DOI Listing
November 2015

The impact of age on survival of diffuse large B-cell lymphoma - a population-based study.

Acta Oncol 2015 Jun 18;54(6):916-23. Epub 2014 Dec 18.

Department of Radiology, Oncology, and Radiation Sciences, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.978367DOI Listing
June 2015

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

Blood 2014 Sep 8;124(10):1570-7. Epub 2014 Jul 8.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-573089DOI Listing
September 2014

Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry.

Acta Oncol 2014 Jul 10;53(7):927-34. Epub 2014 Mar 10.

Department of Internal Medicine, Kalmar County Hospital , Kalmar , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.889850DOI Listing
July 2014

Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.

Leuk Res 2014 Jun 22;38(6):682-90. Epub 2014 Mar 22.

Department of Immunotechnology, Lund University, Lund, Sweden; CREATE Health, Lund University, Lund, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.03.010DOI Listing
June 2014

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial.

Leuk Lymphoma 2014 May 28;55(5):1206-8. Epub 2013 Aug 28.

Department of Radiology, Oncology and Radiation Science, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.825906DOI Listing
May 2014

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody.

BMC Cancer 2012 Jun 27;12:269. Epub 2012 Jun 27.

Department of Immunotechnology, Lund University, BMCD13, Lund, SE-221 84, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495897PMC
June 2012

Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.

Leuk Lymphoma 2012 Sep 16;53(9):1764-8. Epub 2012 Mar 16.

Department of Oncology, Institution of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2012.66
Publisher Site
http://dx.doi.org/10.3109/10428194.2012.666541DOI Listing
September 2012

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

Leuk Lymphoma 2011 Nov 30;52(11):2090-6. Epub 2011 Jun 30.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.593274DOI Listing
November 2011

Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

Leuk Lymphoma 2011 Oct 24;52(10):1929-35. Epub 2011 Jun 24.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.587560DOI Listing
October 2011

Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.

Exp Cell Res 2011 May 13;317(8):1179-91. Epub 2011 Feb 13.

Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2011.02.006DOI Listing
May 2011

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

Eur J Haematol 2011 Feb 22;86(2):124-8. Epub 2010 Dec 22.

Department of Oncology, Helsinki University Central Hospital, Helsinki Genome-Scale Biology Research Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01541.xDOI Listing
February 2011

CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Leuk Lymphoma 2010 Sep;51(9):1643-8

Department of Oncology, Institution of Clinical Sciences, Lund University and Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.492537DOI Listing
September 2010

Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patients.

Mod Pathol 2010 May 26;23(5):686-93. Epub 2010 Feb 26.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.43DOI Listing
May 2010

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

Mod Pathol 2009 Aug 15;22(8):1094-101. Epub 2009 May 15.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.73DOI Listing
August 2009

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

Eur J Haematol 2009 May 9;82(5):364-72. Epub 2009 Jan 9.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01222.xDOI Listing
May 2009

B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule.

Cancer Lett 2008 Feb 3;259(2):138-45. Epub 2007 Dec 3.

Department of Immunotechnology, Lund University, CREATE Health, Lund University, BMC D13, 221 84, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2007.10.031DOI Listing
February 2008

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.

Blood 2008 Jan 12;111(2):800-5. Epub 2007 Oct 12.

Department of Immunotechnology, CREATE Health, BioMedical Center, Lund University, and Department of Pathology, Lund University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-06-093401DOI Listing
January 2008

CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.

Leuk Lymphoma 2007 Sep;48(9):1774-9

Department of Oncology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701494520DOI Listing
September 2007

Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.

Eur J Haematol 2007 Aug;79(2):159-65

Department of Hematology, Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.00882.xDOI Listing
August 2007

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.

Blood 2005 Apr 2;105(7):2908-15. Epub 2004 Dec 2.

Department of Molecular Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-07-2721DOI Listing
April 2005